Results 41 to 50 of about 3,066 (203)
Relugolix/Estradiol/Norethisterone (Norethindrone) Acetate: A Review in Symptomatic Uterine Fibroids
, 2023 The Relugolix/Estradiol/Norethisterone (Norethindrone) Acetate in Uterine Fibroids Adis Drug Evaluation video abstract, script and image slide deck provide a brief overview of the mechanism of action of drug in indication, the administration regimen and ...
Yahiya Y. Syed (6594444)
core +1 more source
Developments with hormonal contraceptives for elephants
Pachyderm, 1996 Only a summary of the presentation was published. Outlines the ongoing research into the use of hormonal contraceptive initiated to develop as an alternative to culling.
Aarde, van
doaj +1 more source
Graphene Oxide Membrane Immobilized Aptamer as a Highly Selective Hormone Removal
Membranes, 2020 Three-dimensional (3D) reduced graphene oxide (rGO) modified by polyethyleneimine (PEI) was prepared and functionalized by fluorophore-labeled dexamethasone-aptamer (Flu-DEX-apt) via π–π stacking interaction.
Siham Chergui +3 more
doaj +1 more source
Contraception and Reproductive Medicine, 2021 Since the introduction of the first modern contraceptive methods, the interlink between bleeding control and contraceptive development has been a dominant and critical factor.
Donna Shoupe
doaj +1 more source
The influence of norethindrone and mestranol on pituitary–adrenal function
, 1968 Female Wistar rats were force-fed either Ortho-Novum (66 μg norethindrone and 1 μg mestranol), norethindrone (66 μg), mestranol (1 μg), or water daily for 1 month.
David R. Usher
core +1 more source
Pharmacokinetic and Drug–Drug Interaction Profiles of the Combination of Tezacaftor/Ivacaftor
Clinical and Translational Science, 2019 Drug–drug interaction (DDI) studies are described for tezacaftor/ivacaftor, a new cystic fibrosis transmembrane conductance regulator modulator therapy for the treatment of cystic fibrosis.
Varun Garg +11 more
doaj +1 more source
, 2016 OBJECTIVE: To assess the proportion of patients satisfied with their treatment before and after a systematic change from norethindrone acetate to dienogest as the first-line progestin for symptomatic endometriosis.
B. Bracco +6 more
core +1 more source
Relugolix/Estradiol/Norethisterone (Norethindrone) Acetate: A Review in Symptomatic Uterine Fibroids
, 2022 Declarations Funding The preparation of this review was not supported by any external funding. Authorship and Conflict of interest Yahiya Y. Syed is a salaried employee of Adis International Ltd/Springer Nature, and declares no relevant conflicts of ...
Yahiya Y. Syed (4897507)
core +1 more source